FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to a new pharmaceutically acceptable salt, 2-hydroxy-3-[5-(morpholine-4-ylmethyl) pyridine-2-yl]-1H-indole-5-carbonitrilcitrate, to a method for making thereof, pharmaceutical compositions containing said salt, and administration of said active salt within a therapy, and particularly in GSK3-related conditions and disorders.
EFFECT: preparation of the new pharmaceutically acceptable salt.
11 cl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| INDOLE DERIVATIVES, METHODS OF OBTAINING THEM (VERSIONS), INTERMEDIATE COMPOUNDS USED FOR OBTAINING THEM, PHARMACEUTICAL COMPOSITION CONTAINING THEM, AND THEIR USE IN TREATING CONDITIONS, RELATED TO GLYCOGEN-SYNTHASE-KINASE-3 | 2003 |
|
RU2338742C2 |
| METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTIONS | 2012 |
|
RU2665021C2 |
| METHODS AND COMPOSITIONS TO IMPROVE COGNITIVE FUNCTIONS | 2012 |
|
RU2792010C2 |
| MEANS OF ANTI-CLONOGENIC ACTIVITY IN RESPECT OF TUMOR HUMAN CELLS | 2016 |
|
RU2648820C2 |
| CATECHOL-O-METHYLTRANSFERASE INHIBITORS AND THEREOF APPLICATION FOR TREATMENT OF PSYCHOTIC DISORDERS | 2011 |
|
RU2563634C2 |
| INHIBITORS OF CATECHOL-O-METHYLTRANSFERASE AND THEREOF APPLICATION IN TREATMENT OF PSYCHIC DISORDERS | 2011 |
|
RU2572624C2 |
| IMIDAZOPYRIDINE OR IMIDAZOPYRIMIDINE DERIVATIVES AS PHOSPHODIESTERASE 10A INHIBITORS | 2010 |
|
RU2502737C2 |
| CATECHOL-O-METHYL TRANSFERASE INHIBITORS AND USE THEREOF IN TREATING PSYCHOTIC DISORDERS | 2011 |
|
RU2586974C2 |
| QUINOLINE CARBOXAMIDE AND QUINOLINE CARBONITRILE DERIVATIVES AS mGluR2 NEGATIVE ALLOSTERIC MODULATORS, COMPOSITIONS AND USE THEREOF | 2012 |
|
RU2610262C2 |
| NOVEL PYRIMIDINE DERIVATIVES AND THEIR APPLICATION IN THERAPY, AS WELL AS APPLICATION OF PYRIMIDINE DERIVATIVES IN MANUFACTURING MEDICATION FOR PREVENTION AND/OR TREATMENT OF ALZHEIMER'S DISEASE | 2006 |
|
RU2433128C2 |
